Haemonetics Corporation (HAE)
HAE moved a median of -0.07% 30 minutes after news, and +0.07% by the close. How HAE actually reacts to news — the realized, point-in-time move the market made, measured across 261 labeled events over the last three years with zero look-ahead.
HAE’s median reaction, across the day.
| Horizon | Median | % positive | Events |
|---|---|---|---|
| 5-min | 0.00% | 43% | 259 |
| 30-min | -0.07% | 44% | 260 |
| 60-min | -0.03% | 50% | 260 |
| to close | +0.07% | 52% | 258 |
| Middle 50% of HAE reactions | -0.74% to +0.58% |
|---|---|
| Median reaction (30-min) | -0.07% |
| Measured reactions | 261 |
Half of all Haemonetics Corporation news events land between -0.74% and +0.58% at 30 minutes.
Reaction stats as of 2026-09-21. Newest measured event . Reaction = percent move vs. the price at the news timestamp.
How HAE reacts, by analyst action.
| Event | Events | Median 30-min | % positive | Median to close |
|---|---|---|---|---|
| Analyst upgrades | 22 | +0.22% | 55% | -0.13% |
| Analyst downgrades | 20 | -0.39% | 50% | -2.07% |
| Coverage initiations | 18 | -0.39% | 22% | +0.38% |
| Rating reiterations | 91 | -0.05% | 43% | -0.26% |
| Price-target raises | 16 | +0.07% | 56% | +0.94% |
| Price-target cuts | 14 | -0.01% | 50% | -0.98% |
Last 3 years, pulled 2026-09-21. Reaction = percent move vs. the price at the news timestamp. Counts and medians only. The same measurement runs across every name in the dataset. See how HAE ranks against every other measured name →
That’s how HAE usually reacts — get an email when it moves on news →Email me when HAE moves on news.
One email per qualifying move — the headline, the measured reaction, and how it compares to HAE's baseline. Nothing else.
Recent HAE events, each with its measured reaction.
| Date | Headline | Event | Source | 5-min | To close |
|---|---|---|---|---|---|
| Form 8-K HAEMONETICS CORP For: Oct 08 | SEC filing · Form 8-K | SEC EDGAR | +4.18% | +6.99% | |
| Haemonetics Sets Date for Publishing Second Quarter Fiscal Year 2027 Results: November 5, 2026 | Press release | PR Newswire | -0.21% | -1.27% | |
| Form 8-K HAEMONETICS CORP For: Aug 18 | SEC filing · Form 8-K | SEC EDGAR | +0.78% | +1.19% | |
| Form 10-Q HAEMONETICS CORP For: Jun 27 | SEC filing · Form 10-Q | SEC EDGAR | -2.83% | -0.87% | |
| Form 8-K HAEMONETICS CORP For: Aug 06 | SEC filing · Form 8-K | SEC EDGAR | -2.83% | -0.87% | |
| Form S-8 HAEMONETICS CORP | SEC filing · Form S-8 | SEC EDGAR | +0.68% | +2.68% | |
| Haemonetics Corporation Announces First Quarter Fiscal 2027 Financial Results Available on Investor Relations Website | Press release | PR Newswire | -2.83% | -0.87% | |
| New Study Offers Additional Evidence for the VASCADE MVP® XL System's Effectiveness in Electrophysiology Procedures with Large Bore Sheaths | Press release | PR Newswire | +0.65% | -0.79% | |
| Form 8-K HAEMONETICS CORP For: Jul 24 | SEC filing · Form 8-K | SEC EDGAR | +0.35% | +4.18% | |
| Martin Madaus Elected to Haemonetics Board of Directors | Press release | PR Newswire | +0.35% | +4.18% | |
| Haemonetics Sets Date for Publishing First Quarter Fiscal Year 2027 Results: August 6, 2026 | Press release | PR Newswire | -0.13% | +1.58% | |
| Form ARS HAEMONETICS CORP For: Mar 28 | SEC filing · Form ARS | SEC EDGAR | +0.32% | +0.13% | |
| Form DEF 14A HAEMONETICS CORP For: Mar 28 | SEC filing · Form DEF | SEC EDGAR | +0.32% | +0.13% | |
| Form DEFA14A HAEMONETICS CORP | SEC filing · Form DEFA14A | SEC EDGAR | +0.32% | +0.13% | |
| Form 8-K HAEMONETICS CORP For: Jun 05 | SEC filing · Form 8-K | SEC EDGAR | +0.86% | +1.68% | |
| Haemonetics Updates Financial Reporting Segments | Press release | PR Newswire | +0.86% | +1.68% | |
| Haemonetics to Present at Goldman Sachs 47th Annual Global Healthcare Conference | Press release | PR Newswire | +0.08% | -0.48% | |
| Form SD HAEMONETICS CORP | SEC filing · Form SD | SEC EDGAR | +1.48% | +1.24% | |
| Form 10-K HAEMONETICS CORP For: Mar 28 | SEC filing · Form 10-K | SEC EDGAR | -0.92% | +5.17% | |
| Form 8-K HAEMONETICS CORP For: May 07 | SEC filing · Form 8-K | SEC EDGAR | +0.67% | -4.75% | |
| Haemonetics Corporation Announces Fourth Quarter Fiscal 2026 Financial Results Available on Investor Relations Website | Press release | PR Newswire | +0.67% | -4.75% | |
| Haemonetics to Present at Bank of America 2026 Healthcare Conference | Press release | PR Newswire | +0.21% | -0.41% | |
| Form 8-K HAEMONETICS CORP For: Apr 27 | SEC filing · Form 8-K | SEC EDGAR | -0.78% | -6.21% | |
| New Study Highlights Safety and Efficacy Profile of Haemonetics' VASCADE MVP® XL in Large-Bore Venous Access Closure Procedures | Press release | PR Newswire | +0.13% | +0.72% | |
| Haemonetics Sets Date for Publishing Fourth Quarter and Fiscal Year 2026 Results: May 7, 2026 | Press release | PR Newswire | -0.81% | +0.74% | |
| Haemonetics Receives FDA Approval for Expanded Labeling of the VASCADE MVP® XL Venous Vascular Closure System | Press release | PR Newswire | -0.94% | +1.66% | |
| Form 8-K HAEMONETICS CORP For: Mar 03 | SEC filing · Form 8-K | SEC EDGAR | +1.36% | +4.71% | |
| Haemonetics Receives FDA Clearance for NexSys® PCS Plasma Collection System with Persona® PLUS Technology | Press release | PR Newswire | +0.22% | -0.61% | |
| Haemonetics to Present at Raymond James 47th Annual Institutional Investors Conference | Press release | PR Newswire | +0.18% | -0.05% | |
| Form 8-K HAEMONETICS CORP For: Feb 12 | SEC filing · Form 8-K | SEC EDGAR | +0.40% | +0.10% | |
| Form 10-Q HAEMONETICS CORP For: Dec 27 | SEC filing · Form 10-Q | SEC EDGAR | -1.15% | -1.41% | |
| Form 8-K HAEMONETICS CORP For: Feb 05 | SEC filing · Form 8-K | SEC EDGAR | -1.15% | -1.41% | |
| Haemonetics Corporation Announces Third Quarter Fiscal 2026 Financial Results Available on Investor Relations Website | Press release | PR Newswire | -1.15% | -1.41% | |
| EQT Life Sciences to exit Vivasure Medical via sale to Haemonetics | Press release | PR Newswire | -0.85% | +0.70% | |
| Form 8-K HAEMONETICS CORP For: Jan 09 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | -2.50% | |
| Haemonetics Acquires Vivasure Medical Limited | Press release | PR Newswire | +0.00% | -2.50% | |
| Vivasure Medical Announces Acquisition by Haemonetics Corporation | Press release | Business Wire | +0.00% | -2.50% | |
| Haemonetics Sets Date for Publishing Third Quarter Fiscal Year 2026 Results: February 5, 2026 | Press release | PR Newswire | +1.07% | +1.85% | |
| Haemonetics to Present at 44th Annual J.P. Morgan Healthcare Conference | Press release | PR Newswire | +0.51% | -0.36% | |
| Form 10-Q HAEMONETICS CORP For: Sep 27 | SEC filing · Form 10-Q | SEC EDGAR | +6.64% | +14.62% | |
| Form 8-K HAEMONETICS CORP For: Nov 06 | SEC filing · Form 8-K | SEC EDGAR | +6.64% | +14.62% | |
| Haemonetics Corporation Announces Second Quarter Fiscal 2026 Financial Results Available on Investor Relations Website | Press release | PR Newswire | +6.64% | +14.62% | |
| Haemonetics Sets Date for Publishing Second Quarter Fiscal Year 2026 Results: November 6, 2025 | Press release | PR Newswire | -0.45% | -2.81% | |
| Form 10-Q HAEMONETICS CORP For: Jun 28 | SEC filing · Form 10-Q | SEC EDGAR | -4.90% | -21.16% | |
| Form 8-K HAEMONETICS CORP For: Aug 07 | SEC filing · Form 8-K | SEC EDGAR | -4.90% | -21.16% | |
| Haemonetics 1st Quarter Fiscal Year 2026 Earnings Release Available on Investor Relations Website | Press release | PR Newswire | -4.90% | -21.16% | |
| Form 8-K HAEMONETICS CORP For: Jul 24 | SEC filing · Form 8-K | SEC EDGAR | +0.19% | -0.49% | |
| Haemonetics Sets Date for Publishing First Quarter Fiscal Year 2026 Results: August 7, 2025 | Press release | PR Newswire | -0.52% | +0.29% | |
| Vivasure Medical Submits PMA Application for PerQseal® Elite and Secures Expanded Venous Indication in Europe | Press release | Business Wire | +0.04% | +0.81% | |
| Form ARS HAEMONETICS CORP For: Mar 29 | SEC filing · Form ARS | SEC EDGAR | +0.36% | +1.29% |
Each reaction is the move the market actually made, measured from the news timestamp. Headlines link through to the HAE section they belong to.
Where else HAE is measured.
HAE earnings → · Analyst actions → · SEC filings →
Other Healthcare names, measured the same way
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| iBio, Inc. (IBIO) | 263 | -0.38% | 43% |
| NOVUS THERAPEUTICS (NVUS) | 263 | -0.14% | 40% |
| Avanos Medical, Inc. (AVNS) | 259 | 0.00% | 45% |
| Enanta Pharmaceuticals, Inc. (ENTA) | 257 | +0.06% | 50% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not.
All Healthcare names, measured the same way →
Every ticker we measure the same way24
Apple (AAPL)
How AAPL actually reacts to news, measured.
NVIDIA (NVDA)
How NVDA actually reacts to news, measured.
Tesla (TSLA)
How TSLA actually reacts to news, measured.
Microsoft (MSFT)
How MSFT actually reacts to news, measured.
Advanced Micro Devices (AMD)
How AMD actually reacts to news, measured.
Amazon (AMZN)
How AMZN actually reacts to news, measured.
Alphabet (GOOG)
How GOOG actually reacts to news, measured.
Meta Platforms (META)
How META actually reacts to news, measured.
Broadcom (AVGO)
How AVGO actually reacts to news, measured.
JPMorgan Chase (JPM)
How JPM actually reacts to news, measured.
Visa (V)
How V actually reacts to news, measured.
Walmart (WMT)
How WMT actually reacts to news, measured.
Eli Lilly (LLY)
How LLY actually reacts to news, measured.
UnitedHealth Group (UNH)
How UNH actually reacts to news, measured.
Netflix (NFLX)
How NFLX actually reacts to news, measured.
Johnson & Johnson (JNJ)
How JNJ actually reacts to news, measured.
Exxon Mobil (XOM)
How XOM actually reacts to news, measured.
Home Depot (HD)
How HD actually reacts to news, measured.
Costco (COST)
How COST actually reacts to news, measured.
Mastercard (MA)
How MA actually reacts to news, measured.
Oracle (ORCL)
How ORCL actually reacts to news, measured.
Salesforce (CRM)
How CRM actually reacts to news, measured.
Bank of America (BAC)
How BAC actually reacts to news, measured.
Coca-Cola (KO)
How KO actually reacts to news, measured.
Walt Disney (DIS)
How DIS actually reacts to news, measured.
Browse all tickers
Every name we’ve measured, in one place.
How the numbers are made.
How is Haemonetics Corporation's median reaction calculated?
Every labeled HAE news event is measured from its own timestamp: the last trade before the news is the base price, and the move is read at fixed horizons — 30 minutes of trading, then the close. The median across 261 events is what this page reports. Point-in-time, zero look-ahead: no event borrows information from a later one.
What counts as a positive reaction?
Any event whose price move is above zero at the horizon, relative to the last trade before the news timestamp. 44% of HAE's measured events are up at 30 minutes; the rest close the window flat or negative.
How often is this page updated?
The news table refreshes automatically as new events are labeled and priced. The reaction medians are re-pulled in batches from the dataset — the figures here are as of 2026-09-21.
Does HAE's past reaction predict its next one?
No. These are realized facts about past events, not forecasts. They describe a distribution — they say nothing certain about any future move.